Ikena Oncology Inc. (NASDAQ: IKNA) Stock Information | RedChip

Ikena Oncology Inc. (NASDAQ: IKNA) Listen to this Section


$1.71
+0.0250 ( +1.49% ) 99.6K

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Market Data


Open


$1.71

Previous close


$1.68

Volume


99.6K

Market cap


$82.52M

Day range


$1.68 - $1.73

52 week range


$1.02 - $5.21

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Feb 02, 2024
8-k 8K-related 14 Jan 18, 2024
8-k 8K-related 13 Nov 09, 2023
10-q Quarterly Reports 70 Nov 09, 2023
8-k 8K-related 12 Oct 11, 2023
def Proxies and info statements 5 Sep 25, 2023
4/a Other 1 Sep 21, 2023
4/a Other 1 Sep 21, 2023
pre Proxies and info statements 4 Sep 15, 2023
4 Insider transactions 1 Sep 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.